Combined antitumor effect of cyclophosphamide and bromodeoxyuridine in BDF1 mice bearing L1210 ascites tumors

Biological and Pharmaceutical Bulletin

Volumn 31, Issue 1, 2008, Pages 57-61

  Kagawa, Yoshiyuki ^a   Noge, Ichiro ^a   Higashigawa, Masamune ^b   Komada, Yoshihiro ^b  

^a UNIVERSITY OF SHIZUOKA   (Japan)

^b MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

4 hydroxycyclophosphamide; 5 bromo 2 deoxyuridine; Antitumor effect; Cyclophosphamide

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; 4 HYDROXYCYCLOPHOSPHAMIDE; BROXURIDINE; CYCLOPHOSPHAMIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; ASCITES TUMOR; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CYTOTOXICITY; DRUG BLOOD LEVEL; DRUG DOSE COMPARISON; DRUG MEGADOSE; DRUG POTENTIATION; IN VITRO STUDY; LEUKEMIA CELL; MALE; MONOTHERAPY; MOUSE; NONHUMAN; SINGLE DRUG DOSE; SURVIVAL RATE; WEIGHT GAIN;

ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BROMODEOXYURIDINE; CYCLOPHOSPHAMIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; LEUKEMIA L1210; MALE; MICE;

EID: 37849000500     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.31.57     Document Type: Article

References (29)

1. Djordjevic D., Szybalski W., J. Exp. Med., 112, 509-531 (1960).
2. Kinsella T. J., Russo A., Mitchell J. B., Rowland J., Jenkins J., Schwade J., Myers C. E., Collins J. M., Speyer J., Kornblith P. A., Int. J. Radiat. Oncol. Biol. Phys., 10, 69-76 (1984).
3. Ensminger W. D., Walker S. C., Stetson P. L., Wagner J. G., Knol J. A., Lawrence T. S., Andrews J. C., Cancer Res., 54, 2121-2124 (1994).
4. Phillips T. L., Levin V. A., Ahn D. K., Gutin P. H., Davis R. L., Wilson C. B., Prados M. D., Wara W. M., Flam M. S., Int. J. Radiat. Oncol. Biol. Phys., 21, 709-714 (1991).
5. Chi K. H., Kunugi K. A., Kinsella T. J., Cancer Res., 54, 2701-2706 (1994).
6. Wendtner C. M., Eichhorst B. F., Hallek M. J., Semin. Hematol., 41, 224-233 (2004).
7. Furlanut M., Franceschi L., Oncology, 65 (Suppl. 2), 2-6 (2003).
8. Pass G. J., Carrie D., Boylan M., Lorimore S., Wright E., Houston B., Henderson C. J., Wolf C. R., Cancer Res., 65, 4211-4217 (2005).
9. Clarke L., Waxman D. J., Cancer Res., 49, 2344-2350 (1989).
10. Roy P., Yu L. J., Crespi C. L., Waxman D. J., Drug Metab. Dispos., 27, 655-666 (1999).
11. Boddy A. V., Yule S. M., Clin. Pharmacokinet., 38, 291-304 (2000).
12. Fleming R. A., Pharmacotherapy, 17, 146S-154S (1997).
13. Kaijser G. P., Beijnen J. H., "A Clinician's Guide to Chemotherapy Pharmacokinetics and Pharmacodynamics," ed. by Grochow L. B., Ames M. M., Williams and Wilkins, Baltimore, 1998, pp. 229-258.
14. Huang Z., Roy P., Waxman D. J., Biochem. Pharmacol., 59, 961-972 (2000).
15. Fraiser L. H., Kanekal S., Kehrer J. P., Drugs, 42, 781-795 (1991).
16. Finley R. S., Balmer C., "Conceps in Oncology Therapeutics," American Society of Health-System Pharmacists, Bethesda, 1998.
17. Russo A., DeGraff W., Kinsella T. J., Gamson J., Glatstein E., Mitchell J. B., Int. J. Radiat. Oncol. Biol. Phys., 12, 1371-1374 (1986).
18. Kagawa Y., Ohkubo T., Higashigawa M., Ido M., Kakito H., Inagaki S., Kojima M., Ooi K., Sakurai M., Cancer Invest., 13, 470-474 (1995).
19. Twentyman P. R., Luscombe M., Br. J. Cancer, 56, 279-285 (1987).
20. Carmichael J., DeGraff W. G., Gazdar A. F., Minna J. D., Mitchell J. B., Cancer Res., 47, 943-946 (1987).
21. Carmichael J., DeGraff W. G., Gazdar A. F., Minna J. D., Mitchell J. B., Cancer Res., 47, 936-942 (1987).
22. Boucher P. D., Ostruszka L. J., Shewach D. S,, Cancer Res., 60, 1631-1636 (2000).
23. Streifel J. A., Howell S. B., Proc. Natl. Acad. Sci. U.S.A., 78, 5132-5136 (1981).
24. Muraoka Y., Matsumura S., Yahara I., Itoh F., Watanabe H., Morishige E., Uno K., Harada Y., Kiso-to-Rinsho, 16, 431-438 (1982).
25. Mancini W. R., Stetson P. L., Lawrence T. S., Wagner J. G., Greenberg H. S., Ensminger W. D., Cancer Res., 51, 870-874 (1991).
26. Kuan H. Y., Smith D. E., Ensmiger W. D., Knol J. A., DeRemer S. J., Yang Z., Stetson P. L., Cancer Res., 56, 4724-4727 (1996).
27. Heidelberger C., Danenberg P. V., Moran R. G., Adv. Enzymol., 54, 58-119 (1983).
28. Moore M. J., Clin. Pharmacokinet., 20, 194-208 (1991).
29. Streifel J. A., Howell S. B., Proc. Natl. Acad. Sci. U.S.A., 78, 5132-5136 (1981).